Stoke Therapeutics Inc (STOK)

SG&A Expenses

$24.57M

Quarterly · Period ending: · USD

STOK logo

STOK SG&A Expenses

Latest reported$24.57M
STOK Quarterly SG&A Expenses ($660.00K → $24.57M)
High-resolution chart · PNG

STOK sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
24,573,000
19,974,000
20,496,000
15,480,000
15,262,000
14,653,000
12,844,000
12,692,000
12,475,000
9,670,000
10,019,000
9,708,000
9,674,000
9,661,000
8,840,000
9,408,000
9,578,000
9,109,000
8,724,000
8,324,999
7,934,000
6,914,000
5,682,000
5,602,000
5,044,000
4,520,000
3,979,000
3,324,000
2,422,000
2,189,000
1,538,000
1,090,000
1,122,000
660,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.